In 2024, biotech company Bicara Therapeutics from Massachusetts had an IPO valued at *** million U.S. dollars. This statistic shows the leading U.S. biotech companies by value of their initial public offerings (IPOs).
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
EY. (June 18, 2025). Value of leading U.S. biotech initial public offerings (IPOs) in 2024 (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 21, 2026, from /statistics/859005/value-of-us-and-eu-biotech-ipos/
EY. "Value of leading U.S. biotech initial public offerings (IPOs) in 2024 (in million U.S. dollars)." Chart. June 18, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 21, 2026. /statistics/859005/value-of-us-and-eu-biotech-ipos/
EY. (2025). Value of leading U.S. biotech initial public offerings (IPOs) in 2024 (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 21, 2026. /statistics/859005/value-of-us-and-eu-biotech-ipos/
EY. "Value of Leading U.S. Biotech Initial Public Offerings (Ipos) in 2024 (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 18 Jun 2025, /statistics/859005/value-of-us-and-eu-biotech-ipos/
EY, Value of leading U.S. biotech initial public offerings (IPOs) in 2024 (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/859005/value-of-us-and-eu-biotech-ipos/ (last visited July 21, 2026)
Value of leading U.S. biotech initial public offerings (IPOs) in 2024 (in million U.S. dollars) [Graph], EY, June 18, 2025. [Online]. Available: /statistics/859005/value-of-us-and-eu-biotech-ipos/
